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Abstract
For the prevention of gastric cancer, the detection of risk factors associated with precancerous conditions may be more informative.
The aim of this study was to identify the risk factors of gastric cancer, including precancerous conditions: atrophic gastritis (AG),
intestinal metaplasia (IM), and dysplasia.
Theclinical andendoscopicﬁndingsof60,261adultswhounderwentgastroduodenoscopyaspartof ahealthcheck-upwere reviewed
retrospectively. Subgroup analysis was conducted according to age, sex, cancer stage, and histology based on Lauren classiﬁcation.
Gastric cancer was diagnosed in 75 patients (0.12%). Both IM and AG were independent risk factors for gastric cancer in all
subgroups. Male, older age, obesity, diabetesmellitus (DM), a salty and spicy diet, andHelicobacter pylori (H. pylori) were signiﬁcantly
associated with precancerous conditions. However, risk factors related to precancerous conditions were different according to age
and sex. In <40 years, H. pylori was the only risk factor related to precancerous conditions, whereas DM with a salty and spicy diet
were additional risk factors in ≥40 years. In female individuals, obesity was signiﬁcant risk factor for precancerous conditions as well
as H. pylori infection.
AG and IM are independent risk factors for gastric cancer. To prevent gastric cancer, H. pylori eradication may be more useful in
<40 years, whereas additional factors such as DM, obesity, salty and spicy diet may be important in female or ≥40 years.
Abbreviations: AG = atrophic gastritis, BMI = body mass index, CI = conﬁdence interval, DM = diabetes mellitus, H. pylori =
Helicobacter pylori, IM = intestinal metaplasia, ORs = odds ratios, WHO = World Health Organization.
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Gastric cancer is the ﬁfth most common cancer worldwide[1,2]
and the third leading cause of cancer mortality. Many peopleEditor: Maria Kapritsou.
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1have been performed health check-up based on organized or
individualized screening to detect of gastric cancer at an early
stage. In Japan and Korea, screening using endoscopy or a
barium study is routinely conducted in all individuals 40 years of
age and older.[3,4] However, unlike the situation in these
countries with a high incidence of gastric cancer, screening is
less appropriate in those with a low incidence of gastric cancer
and may not be cost-effective.[5,6] Therefore, other methods to
recognize individuals at high risk for gastric cancer are needed,
such as via a surveillance strategy based on risk factor analysis. In
the prevention of gastric cancer, the detection of risk factors
associated with precancerous conditions may be more informa-
tive than an assessment of risk factors associated with gastric
cancer, even though the latter are the focus of most studies.
Helicobacter pylori infection is a well-established risk factor
for gastric cancer of both the intestinal and the diffuse type.[7]
Chronic H. pylori gastritis progresses through premalignant
stages of atrophic gastritis (AG), intestinal metaplasia (IM), and
dysplasia to eventually develop into gastric cancer.[7–10]
Premalignant lesions are also an important risk factor for gastric
cancer development. Recently, associations between cancer and
body mass index (BMI) and diabetes mellitus (DM) were
reported. In 2 meta-analyses,[11,12] an increased BMI was shown
to be related to an increased incidence of colorectal cancer. In 2
other studies, an association between DM and cancer of the liver
and colon was proposed.[13,14] However, few studies have
examined the relationship between obesity and DM and the risk
of gastric cancer.
Therefore, in this study, we identiﬁed the risk factors of
gastric cancer including precancerous conditions, among
Park et al. Medicine (2016) 95:44 Medicinesubjects who underwent a health check-up. We also
investigated the association with gastric cancer and metabolic
cause, such as DM and BMI, and analyzed whether the risk
factors in this population differed according to age, sex, and
histology.2. Materials and methods
2.1. Study population
A cross-sectional study was conducted on 60,261 people who
underwent an upper endoscopy at the Health Promotion Center
of the Gangnam Severance Hospital in Seoul, South Korea, from
January 2008 to December 2013. We excluded the following
criteria: individuals who had a personal history of gastric cancer
or any type of cancer, history of gastric surgery including
resection and gastrectomy, any symptoms: weight loss,
abdominal pain, or dyspepsia. For individuals screened more
than twice, the screening results in each case per year were
considered.
This study was approved by the Institutional Review Board of
Gangnam Severance Hospital (Institutional Review Board
number 3-2014-0068).Table 1
The baseline characteristics of study population.
Number (%)
Sex
Male 32,227 (53.5)2.2. Data collection
The clinical data of the study participants were collected by a
review of the electronic medical records. Age was categorized as
younger (<40 years) or older (≥40 years). BMI was classiﬁed
according to the Western Paciﬁc regional ofﬁce of the World
Health Organization (WHO) as normal (<23kg/m2), overweight
(23–24.9kg/m2), and obesity (≥25kg/m2). Smoking history,
alcohol consumption, dietary style (spicy and/or salty), and the
presence of DM were determined in a questionnaire. H. pylori
infection was detected by the following methods: immunoglobu-
lin G speciﬁc for H. pylori in serum (ELFA, enzyme-linked
ﬂuorescence assay, Vidas (bioMerieux Vitek, Inc. Hazelwood,
MO, USA)), rapid urease test (CLOtest; Delta West, Bentley,
Australia), and pathology (Giemsa staining). If the result of at
least 1 of 3 tests (serologic test, rapid urease test, histologic
evaluation) was positive, the patient was determined as positive
for H. pylori infection.Female 21 (28.0)
Age, y (mean±SD) 47.6±11.0
<40 14,239 (23.6)
≥40 46,022 (76.4)
Endoscopic resection 20 (26.7)
Unknown 20 (26.7)
BMI, kg/m2 (mean±SD) 23.4±3.2
<25 40,238 (66.8)
≥25 20,003 (33.2)
Combined DM 2425 (4.0)
Alcohol history 29,975 (49.7)
Smoking
Never 25,367 (42.1)
Ex-smoker 10,068 (16.7)
Current smoker 10,977 (18.2)
Diet style (salty and spicy) 22,177 (36.8)
Helicobacter pylori 24 (32.0)
Negative 11,106 (50.4)
Positive 10,947 (49.6)
Atrophic gastritis 8045 (13.4)
Intestinal metaplasia 5697 (9.5)
BMI=body mass index, DM=diabetes mellitus, SD= standard deviation.2.3. Endoscopic evaluation of gastric cancer and
precancerous conditions
Endoscopic examinations were performed using an endoscope
(GIF-H260; Olympus Medical Systems, Tokyo, Japan)
equipped with an electronic endoscopy system (EVIS LUCERA;
Olympus Medical Systems). Gastric cancer conﬁrmed by
endoscopic biopsy at screening was reported according to
the WHO classiﬁcation: well, moderately, or poorly differenti-
ated tubular adenocarcinomas, or signet ring cell carcinoma.
Histology was assessed according to Lauren classiﬁcation as
intestinal, diffuse, and mixed type. In the 55 patients with
gastric cancer who were treated at our hospital, the cancer
stage was divided into early versus advanced based on ﬁnal
pathologic reports. Precancerous conditions were deﬁned as
AG, IM, and dysplasia. Gastric dysplasia was conﬁrmed by
histologic examination of tissue obtained at endoscopic biopsy.
Gastric atrophy and IM were diagnosed based on the gross
endoscopic ﬁndings reported by the study’s endoscopic
specialists.22.4. Statistical analysis
Categorical variables were analyzed by a x2 test to investigate the
relationships between groups and the various clinical and life-
style features. Continuous variables were analyzed using Student
t test. Data for age and BMI are expressed as the mean±SD.
Risk factors of gastric cancer and precancerous conditions are
represented as odds ratios (ORs) with the 95% conﬁdence
interval (CI), as determined by multiple logistic regression. P<
0.05 was considered to indicate statistical signiﬁcance. All
statistical analyses were performed using the Statistical Package
for the Social Sciences (SPSS) 20.0 for Windows (SPSS, Chicago,
IL).3. Results
3.1. Clinicopathological characteristics of the study
population
Among the 60,261 adults (32,227males; 28,034 females), 75 had
gastric cancer and 11,045 had premalignant lesions. The baseline
characteristics of the subjects who underwent an endoscopic
examination are presented in Table 1. The features indicative of
gastric cancer are listed in Table 2.3.2. Risk factors for gastric cancer
Table 3 shows the risk factors for gastric cancer. According to a
univariate analysis, male sex, obesity, H. pylori infection, and
endoscopically conﬁrmed AG and IM were signiﬁcant. In a
multivariate analysis, only AG (OR=8.47, 95% CI: 4.65–15.40,
P<0.001) and IM (OR=5.80, 95% CI: 3.24–10.35, P<0.001)
were statistically signiﬁcant risk factors.
An analysis of the gastric cancers by histology type (Table 4)
identiﬁed endoscopic AG and IM as signiﬁcant risk factors.
Additional signiﬁcant risk factors for the diffuse type were obesity
Table 2
Clinicopathologic characteristics of gastric cancer.
Gastric cancer (n=75) Number (%)
Age, y (mean±SD) 52.4±12.5
Sex
Male 54 (72.0)
Female 21 (28.0)
Treatment modality
Operation 35 (46.6)
Endoscopic resection 20 (26.7)
Unknown 20 (26.7)
Stage
Early gastric cancer 47 (85.5)
Advanced gastric cancer 8 (14.5)
Location
Cardia 1 (1.3)
Noncardia 74 (98.7)
WHO classiﬁcation
Well differentiated 18 (24.0)
Moderately differentiated 14 (18.7)
Poorly differentiated 19 (25.3)
Signet ring cell 24 (32.0)
Lauren classiﬁcation
Intestinal 36 (48.0)
Diffuse 35 (46.7)
Mixed 4 (5.3)
SD= standard deviation, WHO=World Health Organization.
Park et al. Medicine (2016) 95:44 www.md-journal.com(OR=2.37, 95% CI: 1.10–6.81, P=0.026) and H. pylori
infection (OR=2.41, 95% CI: 1.02–5.67, P=0.044). Endoscop-
ically conﬁrmed AG and IM were also signiﬁcant risk factors in
early- and advanced-stage cancer (Table 5); DM (OR=6.62,
95% CI: 1.32–33.02, P=0.021) was an additional signiﬁcant
risk factor in advanced- but not in early-stage gastric cancer.Table 3
The risk factors for gastric cancer.
Univariate analysis
Control (n, %) Cancer (n, %
Sex
Male 32,173 (53.5) 54 (72.0)
Female 28,013 (46.5) 21 (28.0)
Age, y
<40 14,228 (23.6) 11 (14.7)
≥40 45,960 (76.4) 64 (85.3)
BMI, kg/m2
<25 40,203 (66.8) 39 (52.0)
≥25 19,968 (33.2) 36 (48.0)
DM 2422 (4.0) 3 (4.1)
Alcohol history 9530 (28.5) 15 (37.5)
Smoking
Never 25,362 (54.7) 3 (83.3)
Ex-smoker 10,679 (21.7) 1 (16.7)
Current smoker 10,977 (23.7) 0
Diet style (salty and spicy) 22,144 (36.8) 33 (44.0)
Helicobacter pylori
Negative 11,086 (50.4) 20 (30.8)
Positive 10,902 (49.6) 45 (69.2)
Atrophic gastritis 7990 (13.3) 55 (73.3)
Intestinal metaplasia 5646 (9.4) 51 (68.0)
BMI=body mass index, CI= conﬁdence interval, DM=diabetes mellitus, OR= odds ratio.
33.3. Risk factors for precancerous conditions
Table 6 shows the risk factors for the precancerous
conditions leading to gastric cancer. Male sex (OR=1.39,
95% CI: 1.29–1.50, P<0.001), older age (OR=2.35, 95%
CI: 2.07–2.66, P<0.001), obesity (OR=1.10, 95% CI:
1.01–1.18, P=0.018), DM (OR=1.20, 95% CI: 1.00–-
1.43, P=0.042), diet (salty and/or spicy) (OR=1.12,
95% CI: 1.03–1.20, P=0.003), and H. pylori infection
(OR=1.40, 95% CI: 1.29–1.50, P<0.001) were statistically
signiﬁcant.3.4. Age-related risk factors for gastric cancer and
precancerous conditions
Table 7 shows the risk factors according to age group. In both age
groups, AG and IM were signiﬁcant risk factors for gastric
cancer. In younger versus older individuals, AG (OR=16.6 vs
8.85) and IM (OR=17.2 vs 4.84) had a higher OR for the risk of
gastric cancer. In the young age group, H. pylori was the most
important risk factor related to precancerous conditions.
However in the older age group, DM was an additional risk
factor for precancerous conditions, as were male sex and H.
pylori infection.3.5. Sex-related risk factors for gastric cancer and
precancerous conditions
Table 8 shows the risk factors according to sex. In both males and
females, AG was signiﬁcant risk factors for gastric cancer,
whereas IM was statistically signiﬁcant only for males. For
precancerous conditions, obesity (OR=2.61, 95% CI:
0.93–7.25, P<0.001) was an additional risk factor in females,
as were old age and H. pylori infection.Multivariate analysis
) P OR (95% CI) P
0.001 0.210
1.47 (0.80–2.66)
0.068
0.006 0.132
1
1.48 (0.88–2.45)
0.991
0.209
0.302
0.196
0.002 0.052
1
1.72 (0.99–2.95)
<0.001 8.47 (4.65–15.40) <0.001
<0.001 5.80 (3.24–10.35) <0.001
Table 4
Multivariate analysis of risk factors according to histology of gastric cancer.
Intestinal type (n=36) Diffuse type (n=35)
OR (95% CI) P OR (95% CI) P
Male 3.35 (1.08–9.01) 0.025 Male 0.82 (0.36–1.79) 0.612
Helicobacter pylori 1.41 (0.67–3.12) 0.341 BMI, kg/m2 0.026
Atrophic gastritis 6.39 (2.78–14.64) <0.001 <25 1
Intestinal metaplasia 8.93 (3.62–22.00) <0.001 ≥25 2.37 (1.10–6.81)
Diet style (salty and spicy) 1.46 (0.70–3.03) 0.313
Helicobacter pylori 2.41 (1.02–5.67) 0.044
Atrophic gastritis 11.76 (4.72–29.26) <0.001
Intestinal metaplasia 3.07 (1.38–6.81) 0.006
BMI=body mass index, CI= conﬁdence interval, DM=diabetes mellitus, OR= odds ratio.
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Although the incidence of gastric cancer and mortality from the
disease are declining, it is still a frequent cause of cancer-related
deaths worldwide.[1,2] The mortality from gastric cancers is, in
large part, due to the poor response to treatment of patients with
advanced-stage disease. Thus, efforts at mortality reduction have
been aimed at early intervention with respect to modiﬁable risk
factors.[15–17]
When detected at an early stage, gastric cancer is often curable.
The most common form of gastric cancer is adenocarcinoma,
which can be divided into intestinal and diffuse types.[18] The
intestinal type of gastric cancer is widely accepted to be preceded
by a cascade of premalignant lesions. Because the progression to
gastric cancer is generally a slow process, early detection is
important, as earlier treatment improves both survival and
prognosis and may ultimately alter the natural course of the
disease.[19] Thus, endoscopic surveillance of premalignant gastric
lesions is a useful diagnostic tool. In East Asia, nationwide
screening programs for gastric cancer have resulted in a higher
detection rate of early gastric cancer than is the case in western
countries.[3,4] However, in the latter, nationwide screening
programs may be less appropriate because of the low incidences
of gastric cancer, especially considering that endoscopic screening
is an invasive procedure with a high economic burden.[20,21] In
these countries with a low incidence of gastric cancer the control
of risk factors may be a more appropriate strategy to reduce
mortality from the disease.
Gastric cancer is a multifactorial disease in which H. pylori
infection has been well-established as a primary cause. H. pylori
causes chronic inﬂammation of the gastric mucosa, with theTable 5
Multivariate analysis of risk factors according to stage of gastric can
Early gastric cancer (n=47)
OR (95% CI) P
Male 1.35 (0.50–3.61) 0.546
BMI, kg/m2 0.175
<25 1
≥25 1.78 (0.77–4.11)
Alcohol history 1.80 (0.76–4.19) 0.176
Helicobacter pylori 2.06 (0.80–5.28) 0.130
Atrophic gastritis 7.50 (2.84–19.77) <0.001
Intestinal metaplasia 4.22 (1.64–10.79) 0.003
BMI=body mass index, CI= conﬁdence interval, DM=diabetes mellitus, OR= odds ratio.
4subsequent development of premalignant disease stages leading
to gastric cancer.[7–10] In our study, endoscopic AG and IM were
signiﬁcant risk factors for gastric cancer. Precancerous conditions
such as AG and IM carry a high risk of progression to gastric
cancer. Among the epidemiologically related risk factors for
precancerous conditions,H. pylori infection, older age, and male
sex were signiﬁcant. Additional risk factors for precancerous
conditions were obesity and DM.
H. pylori infection is strongly associated with both intestinal
and diffuse types of gastric cancer.[7,8] Some studies have
reported cost-effective cancer prevention based on early
intervention, such as H. pylori eradication,[22,23] but this
approach has yet to be conﬁrmed. However, our results support
early intervention to eradicate H. pylori as a strategy for cancer
prevention, given that H. pylori infection and male sex were the
only risk factors for precancerous conditions in individuals <40
years. This age group also had a higher OR ofH. pylori infection.
The risk factors for precancerous conditions associated with age
≥40 years were, in addition toH. pylori infection, DMand a salty
or spicy diet. Previous studies reported that, in addition to older
age, males are at higher risk of noncardia gastric cancer than
females, in agreement with the ﬁndings of this study.[24,25]
From our data, gross endoscopic AG and IMwere identiﬁed as
independent risk factors for gastric cancer regardless of the
subgroup analysis. Both AG and IM had a higher OR for the risk
of gastric cancer in individuals<40 years than in those≥40 years.
Current recommendations in South Korea and Japan are that all
adults>40 years should undergo regular screening every 2 years,
regardless of symptoms. Our results suggest the need for regular
surveillance for asymptomatic individuals younger than 40 years
of age in whom AG or IM is detected.cer.
Advanced gastric cancer (n=8)
OR (95% CI) P
DM 6.62 (1.32–33.02) 0.021
Atrophic gastritis 18.08 (1.90–171.64) 0.012
Intestinal metaplasia 8.14 (1.45–45.44) 0.017
Table 6
The risk factors for precancerous conditions (n=11,045).
Univariate analysis Multivariate analysis
Control (n, %) Precancerous conditions (n, %) P OR (95% CI) P
Sex <0.001 <0.001
Male 25,525 (51.9) 6702 (60.7) 1.39 (1.29–1.50)
Age, y <0.001
<40 13,030 (26.5) 1209 (10.9) 1 <0.001
≥40 36,186 (73.5) 9836 (89.1) 2.35 (2.07–2.66)
BMI, kg/m2 <0.001 0.018
<25 33,329 (67.7) 6913 (62.6) 1
≥25 15,873 (32.3) 4131 (37.4) 1.10 (1.01–1.18)
DM 1984 (3.9) 491 (4.4) 0.013 1.20 (1.00–1.43) 0.042
Alcohol history 7821 (28.5) 1724 (28.6) 0.885
Smoking 0.035 0.132
Never 20,418 (54.6) 4949 (55.0) 0.94 (0.86–1.03)
Ex-smoker 8200 (21.9) 1868 (20.7) 1.05 (0.96–1.15)
Current smoker 8790 (23.5) 2187 (24.3)
Diet style (salty and spicy) 18,007 (36.6) 4170 (37.8) 0.022 1.12 (1.03–1.20) 0.003
Helicobacter pylori <0.001 <0.001
Negative 8934 (52.5) 2172 (43.1) 1
Positive 8078 (47.5) 2869 (56.9) 1.40 (1.29–1.50)
BMI=body mass index, CI= conﬁdence interval, DM=diabetes mellitus, OR= odds ratio.
Park et al. Medicine (2016) 95:44 www.md-journal.comA signiﬁcant risk factor in diffuse-type gastric cancer is obesity.
Based on our results, in gastric carcinogenesis, diffuse-type
cancer differs from the intestinal type which follows a multistep
cascade from premalignant lesions. Advanced-stage gastric
cancer may be inﬂuenced by additional factors related to disease
progression that are not determinants in early-stage cancer. For
example, DM was a meaningful factor only for advanced-stage
gastric cancer.
Obesity is one of the strongest emerging risk factors for many
types of cancer.[11,12] DM affects populations throughout the
world and its association with liver and colon cancers has been
reported.[13,14] However, the few studies that have attempted to
establish an association between BMI, DM, and the risk of gastric
cancer have yielded conﬂicting results.[26–28] In our study, obesity
(BMI ≥25kg/m2) was associated with diffuse-type adenocarci-
noma. Furthermore in females, obesity poses an increased risk of
precancerous conditions. This is matched up to the fact that
diffuse type gastric cancer is more associated with female
different from intestinal type. Thus, weight reduction may be
more important in female to prevent gastric cancer.Table 7
The risk factors according to age group.
Age <40
Gastric cancer Precancerous conditions
OR (95% CI) P OR (95% CI) P
Male 1.50 (1.17–1.93) 0.001 M
BMI, kg/m2 (mean±SD) 0.765 B
<25 1
≥25 1.50 (0.81–1.31)
Alcohol history 1.25 (0.98–1.59) 0.063 D
Helicobacter pylori 3.65 (0.42–31.67) <0.001 D
Atrophic gastritis 16.55 (3.76–72.85) <0.001 H
Intestinal metaplasia 17.24 (3.87–76.70) <0.001 A
In
BMI=body mass index, CI= conﬁdence interval, DM=diabetes mellitus, OR= odds ratio, SD= standar
5Both obesity and DM are metabolic diseases that are becoming
increasingly common. While known environmental factors, such
as smoking and a salty diet are still important risk factors in
gastric cancer, DM and obesity have been gaining in importance,
reﬂecting changing life styles. In both conditions, the accumula-
tion of adipose tissue together with hyperinsulinemia and insulin
resistance can impair apoptosis and stimulate gastric mucosal
proliferation.[29,30] Chronic injury of the gastric mucosa can then
lead to the development of gastric cancer. Tobacco also could
lead to mucosal damage through direct contact or indirectly
through the blood ﬂow. Tobacco contains several chemical
carcinogens, and high levels of carcinogenic N-nitroso com-
pounds, which are often associated with gastric cancer, have been
found in the bloodstreams of smoker.[31,32] Although smoking is
a well-known risk factor for gastric cancer, it was not a signiﬁcant
risk factor identiﬁed in the present study. This is because this
researach was a retrospective study and depended on the answers
given by the patients in the survey.
This study suggests the need to reconsider the risk factors of
gastric cancer. A strength of our studywas the subgroup analyses,Age ≥40
Gastric cancer Precancerous conditions
OR (95% CI) P OR (95% CI) P
ale 1.37 (0.73–2.55) 0.326 1.40 (1.29–1.50) <0.001
MI, kg/m2 (mean±SD) 0.152 0.118
<25 1 1
≥25 1.49 (0.86–2.55) 1.06 (0.98–1.14)
M 1.23 (1.04–1.45) 0.015
iet style (spicy and salty) 1.14 (1.05–1.22) <0.001
elicobacter pylori 1.66 (0.92–2.95) 0.088 1.39 (1.29–1.49) <0.001
trophic gastritis 8.85 (4.54–17.25) <0.001
testinal metaplasia 4.84 (2.61–8.96) <0.001
d deviation.
[2] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and
Table 8
The risk factors according to sex.
Male Female
Gastric cancer Precancerous conditions Gastric cancer Precancerous conditions
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
Age, y 0.671 <0.001 Age, y 0.458 <0.001
<40 1 1 <40 1 1
≥40 0.84 (0.36–1.90) 2.14 (1.84–2.48) ≥40 2.18 (0.27–16.99) 2.41 (1.99–2.92)
DM 1.27 (0.94–1.72) 0.117 BMI, kg/m2 (mean±SD) 0.067 <0.001
Helicobacter pylori 1.42 (0.77–2.61) 0.256 1.44 (1.28–1.61) <0.001 <25 1 1
Atrophic gastritis 9.08 (4.36–18.89) <0.001 ≥25 2.61 (0.93–7.25) 1.44 (1.23–1.67)
Intestinal metaplasia 6.98 (3.38–14.39) <0.001 Helicobacter pylori 3.57 (0.99–12.75) 0.050 1.70 (1.48–1.93) <0.001
Atrophic gastritis 8.36 (2.63–26.36) <0.001
Intestinal metaplasia 2.78 (0.93–8.20) 0.065
BMI=body mass index, CI= conﬁdence interval, DM=diabetes mellitus, OR= odds ratio, SD= standard deviation.
Park et al. Medicine (2016) 95:44 Medicinewith respect to histology and cancer stage in the case of gastric
cancer, and age and sex in the case of gastric cancer and
precancerous conditions. Because gastric cancer is one of the
representative heterogeneous cancers, as it shows different
biological behaviors according to age, sex, and histologic type.
To our knowledge, although a premalignant stage, including
both AG and IM, is known to be a high risk for the development
of gastric cancer, few studies have focused on identifying the risk
factors leading to these precancerous conditions, which would
allow an earlier intervention. Moreover, the present study
provides support for the importance of metabolic disease control
in the prevention of gastric cancer.
There were several limitations to our study. First, AG and IM
were not described according to their extent and severity but,
rather, based on gross endoscopic ﬁndings, which were not
biopsy proven. However, biopsy was not considered appropriate
in the study population because there were no doubtful lesions
and the procedure is both invasive and costly. Since the
endoscopists who contributed to this study each had >3 years
of experience, their assessments were considered reliable and the
detection of AG and IM was considered sufﬁcient. Second, a
family history of gastric cancer was not included in the analysis.
Third, the salty and spicy diet was analyzed based on a
questionnaire, not on an objective index. Our questionnaire does
not include the amount or concentration of sodium in the
ingested food. However, we consider that the dietary habits
revealed by a questionnaire can reﬂect the diet style of the subject.
These may have been due to the retrospective nature of this study,
in which complete records were not available and some
important data may have been missing.
In conclusion, endoscopically conﬁrmed AG and IM are
independent risk factors for AG, IM, dysplasia, and gastric cancer
in all subgroups. To prevent gastric cancer,H. pylori eradication
may be the most important in individuals younger than 40 years,
whereas additional factors such as DM, salty and spicy diet may
be important in older than 40 years. Obesity is important risk
factor in female to prevent gastric cancer, especially diffuse type.References
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